Related references
Note: Only part of the references are listed.Responses to Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Metaplastic Carcinoma of the Breast: Biologic Rationale and Implications for Stem-Cell Research in Breast Cancer
Stacy Moulder et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Overall Survival and Post-Progression Survival in Advanced Breast Cancer: A Review of Recent Randomized Clinical Trials
Everardo D. Saad et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy
Fatima Cardoso et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Characteristics and treatment of metaplastic breast cancer: Analysis of 892 cases from the National Cancer Data Base
Christopher M. Pezzi et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature
Alberto Luini et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Biphasic metaplastic sarcomatoid carcinoma of the breast
BT Hennessy et al.
ANNALS OF ONCOLOGY (2006)
Metaplastic carcinoma of the breast Clinical presentation, treatment results and prognostic factors
AD Al Sayed et al.
ACTA ONCOLOGICA (2006)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
